GAO warns unanticipated errors are possible in ICD-10 transition | Study evaluates PET/CT staging in patients with melanoma | Team explores drivers of memory problems after childhood brain tumors
September 25, 2015
CONNECT WITH SNMMI LinkedInFacebookTwitterYoutube
SNMMI SmartBrief
News for nuclear medicine and molecular imaging professionals

Top Story
GAO warns unanticipated errors are possible in ICD-10 transition
A Government Accountability Office report says the CMS's true ability to process ICD-10 codes won't be known until after the Oct. 1 transition despite extensive testing and validation beforehand. Unanticipated errors could undermine the processing of Medicare claims, but the report emphasized that the CMS is taking steps to minimize problems and will offer technical support. The cost of updating CMS systems for the transition is currently estimated at about $116 million. (9/23)
Share: LinkedInTwitterFacebookGoogle+Email
Clinical News & Research
Study evaluates PET/CT staging in patients with melanoma
A study in JAMA Oncology calls for clinical trial evaluation of preoperative melanoma staging with PET/CT. The study reported a 67% false-positive rate in identifying metastatic melanoma with sentinel lymph node mapping. "We recommend that PET/CT staging be reevaluated as a category 2B recommendation by the [National Comprehensive Cancer Network] and its use further evaluated prospectively in a clinical trial," the researchers wrote. Healio (free registration)/HemOnc Today (9/24)
Share: LinkedInTwitterFacebookGoogle+Email
Team explores drivers of memory problems after childhood brain tumors
Whole-brain functional MRI scans of adult survivors of pediatric posterior fossa revealed a significantly activated left superior/middle frontal gyri and left parietal lobe when using their working memories, according to a study in the Journal of the International Neuropsychological Society. The finding sheds light on the physiological mechanisms behind cognitive difficulties that survivors of childhood brain tumors face, researcher Tricia King said. release (9/24)
Share: LinkedInTwitterFacebookGoogle+Email
Scientists modify white blood cells to deliver neurotropic factors
Researchers with the University of North Carolina's Center for Nanotechnology in Drug Delivery reported in the journal PLOS ONE that they have modified macrophages to produce glial cell-line derived neurotropic factor. The cells were associated with reductions of neuroinflammation and brain cell damage in mouse models of Parkinson's disease. (9/23)
Share: LinkedInTwitterFacebookGoogle+Email
Researchers collaborate on inflammatory pathway blockers to treat cancer
Melissa Singh, a fellow at Fannin Innovation Studio and a former postdoctoral fellow at the University of Texas MD Anderson Cancer Center, will lead a new startup named ACF Pharmaceuticals. Singh and her staff will work with researchers at MD Anderson and Cayman Chemical to develop pathway blockers to treat inflammation-induced malignancies. Xconomy (9/21)
Share: LinkedInTwitterFacebookGoogle+Email
Industry Report
Late-stage trial promising for Avastin biosimilar
In a Phase III trial, Amgen's and Allergan's biosimilar, ABP 215, performed as well as its reference drug, Roche Holding's Avastin, or bevacizumab, in treating non-small cell lung cancer. The trial showed clinical equivalence between the two in objective response rate and safety. PharmaTimes (U.K.) (9/24)
Share: LinkedInTwitterFacebookGoogle+Email
Health Policy
ACA is not the job-killer some predicted
Only 4% of employers subject to the Affordable Care Act's mandate to offer health insurance said they changed some positions from full- to part-time to avoid hitting the mandate's threshold, according to the latest Kaiser Family Foundation/Health Research & Education Trust survey. The same percentage said they will not hire as many full-time employees as previously planned because of the law. CNNMoney (9/22)
Share: LinkedInTwitterFacebookGoogle+Email
Grants and Funding
U. of Miami facility awarded $450,000 to study breast cancer
The Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine has received a $450,000 grant from Susan G. Komen for breast cancer research. The grant is the 20th the center has gotten from the foundation. These funds will go to the study of the RAGE protein and the role it plays in cancerous cells. "In a normal sort of cell, you don't see very much of this protein. When you have a chronic inflammatory state, such as what's present in cancer, you see a lot more of it," said lead researcher Barry Hudson. The Miami Herald (tiered subscription model) (9/23)
Share: LinkedInTwitterFacebookGoogle+Email
Advancing Health Care
Canadian veteran with brain injury uses exoskeleton to help him walk again
Former Canadian soldier Trevor Greene, who suffered a serious brain injury in Afghanistan, is now walking with the aid of a ReWalk exoskeleton. The device was previously used only for people with spinal cord damage. Ryan D'Arcy, a neuroscientist at Simon Fraser University in British Columbia, has been using MRIs of Greene's head to study how the brain rewires itself after brain trauma. Stars and Stripes (tiered subscription model) (9/24)
Share: LinkedInTwitterFacebookGoogle+Email
Understand key developments in computing devices and image processing software
Grasp the principles, design, capabilities and limitations of computers in the context of nuclear medicine with Computers in Nuclear Medicine: A Practical Approach, 2nd Edition. This top-seller is your comprehensive guide to understanding computing tools in nuclear medicine imaging. Pick up a copy today!
Share: LinkedInTwitterFacebookGoogle+Email
Just released: The SNMMI "Basic Science" combo series
Get a comprehensive overview of the basic science of nuclear medicine with this newly released series, featuring 20 in-depth online lectures. Topics include Basic Radiation Protection In Nuclear Medicine, Radiation Detectors, SPECT Data Acquisition and Quality Control, Computers in Nuclear Medicine, Emission Tomography and Image Reconstruction and more. AMA, ACPE and VOICE credit available. Learn more and get started today.
Share: LinkedInTwitterFacebookGoogle+Email
Success seems to be largely a matter of hanging on after others have let go."
-- William Feather,
Share: LinkedInTwitterFacebookGoogle+Email
The news summaries appearing in SNMMI SmartBrief are based on original information from multiple internet sources and are produced by SmartBrief, Inc., an independent e-mail newsletter publisher. The items above are not selected or reviewed by SNMMI prior to publication. Questions and comments may be directed to SmartBrief at
Subscriber Tools
Please contact one of our specialists for advertising opportunities, editorial inquiries, job placements, or any other questions.
Advertising:  Meryl Harold
  P: 202.407.7828
Editor:  Melissa Turner

Download the SmartBrief App  iTunes / Android
iTunes  Android
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2015 SmartBrief, Inc.®
Privacy policy |  Legal Information